A Study of LY3015014 in Participants With High Cholesterol

NCT01890967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

527

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: LY3015014
DRUG: Placebo
DRUG: Statin
DRUG: Ezetimibe

Sponsor

Eli Lilly and Company